FinlandFinland

Photodynamic therapy blocks spread of cancer

11.02.2011

Helsinki – Using laser light to destroy tumour cells lodged in lymphatic vessels can halt the spread of cancer, Finnish researchers headed by Tuomas Tammela have demonstrated. Their approach to destroy the tumour cells, which use the tumour-associated vessels as a kind of motorway to spread around the whole body, with help of photodynamic therapy (Science Translational Medicine, DOI: 10.1126/scitranslmed.3001699), opens the door to fight the formation of metastases, which cause 90% of cancer deaths. To test their hypothesis that destruction of tumour-cells on their journey to the lymph nodes can reduce recurrence of cancer after removal of primary tumours the Finnish researchers made use of the light-activated cytotoxic pro-drug verteporfin, which is already marketed by Swiss Novartis AG to eliminate abnormal blood vessels that form in the course of wet macular degeneration. In mice, in which the researcher had induced the formatation of a primary tumor, treatment with the pro-drug and its subsequent activation through an infrared laser reduced the rate of cancer relapse from 65 percent to 10 percent. In a pig model, Tammela et al. showed that the drug acts as a blocker of lymphangiogenesis, the formation of new tumour associated lymphatic vessels. Pig’s lymphatic vessels became fragmented and clogged after treatment with the drug, hinting that photodynamic therapy may be able to destroy lymphatic vessels and also eradicate intralymphatic tumor cells nestled deep within tissues of human cancer patients. Up to now, treatment practice has not paid too much attention to residual tumour cells in metastatic transit inside the lymphatic vessels. The new findings may chance that.

FinlandFinland

08.03.2012

The vaccine research centre of the University of Tampere in Finland has out­licenced a candidate combined prophylactic vaccine against norovirus and rota­virus infections. The Japanese vaccine venture UMN Pharma Inc. acquired the...

FinlandFinland

07.03.2012

Finnish protein manufacturer Vectron Biosolutions AS has completed a study comparing different expression technologies. According to Vectron, their proprietary E. coli expression technology gave higher yields for seven out of ten...

FinlandFinland

02.03.2012

Lappeenranta – Finnish paper industry major UPM plans to invest in an industry-scale biorefinery producing biofuels from crude tall oil, a by-product of the wood pulp manufacturing process. UPM’s total investment will amount to...

FinlandFinland

18.12.2011

Helsinki/Göttingen – Finnish laboratory supplier Biohit Oyj has sold its liquid handling business for €68m to German process and labtech provider Sartorius AG. Osmo Suovaniemi, founder and Chairman of the Board at Biohit,...

FinlandFinland

17.12.2011

Porvoo/Chalfont St. Giles – GE Healthcare and Neste Jacobs have formed a strategic alliance to drive worldwide self-sufficiency in blood plasma fractionation. Finnish-based Neste Jacobs Oy, a global expert in plant engineering...

FinlandFinland

31.10.2011

Bresso/Turku – The wedding's off between Newron and Biotie. The bride has run away. Shares in Italy's Newron Pharmaceuticals plunged after its proposed merger with Biotie Therapies Corp was called off by the Finnish firm....

FinlandFinland

28.09.2011

Turku/ Bresso – It is both good and bad news for the Italian biotechnology sector: Finnish Biotie Therapies ASA has signed an agreement to acquire Newron Pharmaceuticals S.p.A. for €45 million. On the down side, Italy loses one...

FinlandFinland

04.04.2011

Hafnarfjodur – Actavis Group CEO Claudio Albrecht announced at the beginning of February that the company may go public within the next 2-3 years, although it isn’t clear whether the generics manufacturer would conduct an IPO,...

Displaying results 1 to 10 out of 96

1-10 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-finland/article/photodynamic-therapy-blocks-spread-of-cancer.html

Product of the week

Products

Events

All Events

Current issue

All issues